rs80338784
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_000334.4(SCN4A):c.2006G>A(p.Arg669His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,012 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000334.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN4A | NM_000334.4 | c.2006G>A | p.Arg669His | missense_variant | 12/24 | ENST00000435607.3 | NP_000325.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN4A | ENST00000435607.3 | c.2006G>A | p.Arg669His | missense_variant | 12/24 | 1 | NM_000334.4 | ENSP00000396320 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000805 AC: 2AN: 248518Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 134772
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461012Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 726742
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hypokalemic periodic paralysis, type 2 Pathogenic:1Other:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 01, 2002 | - - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Familial hyperkalemic periodic paralysis Pathogenic:1Other:1
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 17, 2021 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects SCN4A function (PMID: 11102465, 11912116, 21881211, 25024265). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 5911). This missense change has been observed in individual(s) with hypokalemic periodic paralysis (PMID: 10599760, 18162704, 21841462). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs80338784, gnomAD 0.009%). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 669 of the SCN4A protein (p.Arg669His). - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Athena Diagnostics | Mar 21, 2023 | The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). This variant appears to occur de novo in multiple individuals with clinical features of hypokalemic periodic paralysis. Assessment of experimental evidence suggests this variant results in abnormal protein function. (PMID: 11102465, 11912116, 21881211, 25024265) The variant is located in a region that is considered important for protein function and/or structure. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at